More about
Relapsed/Refractory Lymphomas
News
February 23, 2024
2 min read
Save
CAR-T recipients report higher rates of ‘potentially serious’ toxicities
Individuals with relapsed or refractory lymphoma who received chimeric antigen receptor T-cell therapy experienced a wide range of adverse events compared with those who received other treatments, study results showed.
News
June 26, 2023
3 min read
Save
Data could guide decisions on treatment of relapsed/refractory lymphoma during pregnancy
Patients diagnosed with relapsed or refractory lymphoma during pregnancy demonstrated a high rate of OS but low PFS rate, according to study results published in Blood Advances.
News
July 17, 2021
5 min read
Save
Role of allogeneic HSCT fading in lymphoma management
As targeted therapies and novel treatments emerge, allogeneic hematopoietic cell transplantation has taken a backseat to immunotherapy in the treatment of lymphoma.
News
June 14, 2021
7 min read
Save
Treatment landscape promising for relapsed or refractory diffuse large B-cell lymphoma
Nearly 30,000 new cases of diffuse large B-cell lymphoma are diagnosed annually in the United States.